In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.
Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses / Torricelli, Paola; Filardo, Giuseppe; Kon, Elizaveta; Fini, Milena. - In: INTERNATIONAL ORTHOPAEDICS. - ISSN 0341-2695. - STAMPA. - 35:11(2011), pp. 1747-1748. [10.1007/s00264-011-1312-9]
Reply to comments of Carmona et al. to the article: Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses
FILARDO, GIUSEPPE;KON, ELIZAVETA;FINI, MILENA
2011
Abstract
In a recently published study, we documented our experience using platelet-rich plasma (PRP) and concentrated bone marrow mononucleated cells (BMMNCs) for the treatment of musculoskeletal injuries (ligament and tendon overuse injuries) in competition horses refractory to other therapies [1]. We evaluated number of cells and presence of growth factors (GFs) injected, and performed follow-ups on horses weekly, up to one year. The results of our study showed a marked improvement in the degree of lameness, with 84.6% of horses returning to competition, and a direct correlation between number of platelets injected and clinical outcome.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
